Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Back Pain
Research from University of Helsinki provide new insights into back pain
May 12th, 2008
According to recent research published in the journal BMC Medicine, "Some patients with long-standing low back pain will benefit from treatment with strong opioids. However, it would be helpful to predict which patients will have a good response." "A fixed-term opioid trial has been recommended, but there is little evidence to suggest how long this trial should be. We assessed data from a large-scale randomized comparison of transdermal fentanyl (TDF) and sustained-release oral morphine (slow-release morphine; SRM) to determine characteristics of treatment responders. This was a secondary analysis of a previously published 13-month randomized trial involving 680...
Source: Biotech Business Week (2008-05-12)
|
